↓ Skip to main content

Dove Medical Press

Article Metrics

Inhibition of B7-1 (CD80) by RhuDex® reduces lipopolysaccharide-mediated inflammation in human atherosclerotic lesions

Overview of attention for article published in Drug Design, Development and Therapy, May 2014
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (60th percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter
3 tweeters

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
14 Mendeley
Title
Inhibition of B7-1 (CD80) by RhuDex® reduces lipopolysaccharide-mediated inflammation in human atherosclerotic lesions
Published in
Drug Design, Development and Therapy, May 2014
DOI 10.2147/dddt.s59594
Pubmed ID
Authors

Andreas Doesch, Li Zhao, Christian Gleissner, Mohammadreza Akhavanpoor, David Rohde, Deniz Okuyucu, Maani Hakimi, Hugo A. Katus, Christian Erbel, Thomas Dengler

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 14 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 14 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 3 21%
Student > Bachelor 3 21%
Student > Master 2 14%
Unspecified 1 7%
Researcher 1 7%
Other 1 7%
Unknown 3 21%
Readers by discipline Count As %
Agricultural and Biological Sciences 3 21%
Pharmacology, Toxicology and Pharmaceutical Science 2 14%
Medicine and Dentistry 2 14%
Unspecified 1 7%
Immunology and Microbiology 1 7%
Other 1 7%
Unknown 4 29%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 September 2015.
All research outputs
#2,404,954
of 6,010,468 outputs
Outputs from Drug Design, Development and Therapy
#191
of 853 outputs
Outputs of similar age
#50,974
of 134,426 outputs
Outputs of similar age from Drug Design, Development and Therapy
#8
of 39 outputs
Altmetric has tracked 6,010,468 research outputs across all sources so far. This one has received more attention than most of these and is in the 58th percentile.
So far Altmetric has tracked 853 research outputs from this source. They receive a mean Attention Score of 2.2. This one has done well, scoring higher than 77% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 134,426 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 60% of its contemporaries.
We're also able to compare this research output to 39 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.